FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Asmuth

Research Profile

Disorders

Concepts & Ideas

Procedures

Living Beings

HIV-1
HIV

Chemicals & Drugs

Anatomy

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Byambaa Enkhmaa; Xiao-Dong Li; Richard B Pollard; Wei Zhang; Adnan Abbuthalha; Erdembileg Anuurad; David M Asmuth; William Dotterweich; Lars Berglund
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
Jacob Lalezari; Shannon Lawrence; David M Asmuth; Arnaldo Casiró; Jie Chen; Gloria Dubuc-Patrick; Joseph McCarville; Keith Pietropaolo; John Sullivan-Bólyai; Hugo Vargas; Xiao-Jian Zhou; Douglas Mayers
Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection.
Philip M Grant; Sudheesh Kanthikeel; Lauren Komarow; Michael M Lederman; Savita Pahwa; Richard B Pollard; Aaron Richterman; Janet Andersen; David M Asmuth; Sridevi Devaraj; Andrew R Zolopa; Irini Sereti
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Asmuth (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Byambaa Enkhmaa; Xiao-Dong Li; Richard B Pollard; Wei Zhang; Adnan Abbuthalha; Erdembileg Anuurad; David M Asmuth; William Dotterweich; Lars Berglund
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(2):387-92.
2012: Jacob Lalezari; Shannon Lawrence; David M Asmuth; Arnaldo Casiró; Jie Chen; Gloria Dubuc-Patrick; Joseph McCarville; Keith Pietropaolo; John Sullivan-Bólyai; Hugo Vargas; Xiao-Jian Zhou; Douglas Mayers
Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection.
Antimicrobial agents and chemotherapy 2012;56(12):6372-8.
2012: Philip M Grant; Sudheesh Kanthikeel; Lauren Komarow; Michael M Lederman; Savita Pahwa; Richard B Pollard; Aaron Richterman; Janet Andersen; David M Asmuth; Sridevi Devaraj; Andrew R Zolopa; Irini Sereti
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.
The Journal of infectious diseases 2012;206(11):1715-23.
2012: David M Asmuth; Timothy Hayes; Thomas H Knight; Zhong-Min Ma; Surinder Mann; Gregory P Melcher; Christopher J Miller; Paolo Troia-Cancio; Tammy Yotter; Anthony Albanese; Richard B Pollard
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
AIDS (London, England) 2012;26(13):1625-34.
2012: Jonathan J Hubbard; David M Asmuth; Lisa Barrett; Teresa Greenwell-Wild; Richard A Lempicki; Robert L Murphy; Richard B Pollard; Sharon M Wahl; Jun Yang; Shyam Kottilil
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.
The Journal of infectious diseases 2012;205(9):1443-7.
2012: Aarthi Chary; Robert Eisen; Thomas H Knight; Mark A Winters; David M Asmuth; Mark Holodniy
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Journal of medical virology 2012;84(3):431-7.
2012: Marco Schunter; Barbara L Shacklett; Timothy L Hayes; Paul A Luciw; Delandy McConnell; David M Asmuth; Stig Bengmark; Charles L Bevins; Jennifer Brown; Hiutung Chu; Sean S Crawford; J William Critchfield
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
BMC complementary and alternative medicine 2012;12():84.
2012: Maura Manion; Kathy Medvik; Robert Murphy; Richard B Pollard; Benigno Rodriguez; Robert T Schooley; Scott F Sieg; David M Asmuth; Edward Barker; Kirsten E Brady; Nick Funderburg; Clifford V Harding; Gareth Hardy; Alan Landay; Michael M Lederman
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
PloS one 2012;7(1):e30306.
2011: Collin L Ellis; Timothy L Hayes; Thomas H Knight; Chin-Shang Li; Zhong-Min Ma; Archana H Maniar; Surinder K Mann; Christopher J Miller; Heather A Overman; Richard B Pollard; John C Rutledge; Natalia Torok; Paolo V Troia-Cancio; Jian Wu; Tammy Yotter; Anthony Albanese; David M Asmuth
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
Journal of acquired immune deficiency syndromes (1999) 2011;57(5):363-70.
2011: Paolo Troia-Cancio; David M Asmuth
Lessons from maraviroc clinical trials.
Expert review of anti-infective therapy 2011;9(6):649-51.
2011: Hiromi Imamichi; Gerald Degray; David M Asmuth; Margaret A Fischl; Alan L Landay; Michael M Lederman; Irini Sereti
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.
AIDS (London, England) 2011;25(2):159-64.
2010: David M Asmuth; James Goodrich; David A Cooper; Richard Haubrich; natasa rajicic; Bernard Hirschel; Howard Mayer; Hernan Valdez
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2.
Journal of acquired immune deficiency syndromes (1999) 2010;54(4):394-7.
2010: David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
The Journal of infectious diseases 2010;201(11):1686-96.
2010: Mark A Winters; Aarthi Chary; Robert Eison; David M Asmuth; Mark Holodniy
Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
Journal of medical virology 2010;82(5):791-8.
2010: David M Asmuth; Elizabeth L Brown; Mark J DiNubile; Xiao Sun; Carlos del Rio; Clayton D Harro; Michael C Keefer; James Kublin; Sheri A Dubey; Lisa S Kierstead; Danilo R Casimiro; John W Shiver; Michael N Robertson; Erin K Quirk; Devan V Mehrotra
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.
The Journal of infectious diseases 2010;201(1):132-41.
2009: Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel MORRE; Renaud Buffet; Guido Silvestri; Michael M Lederman
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
Blood 2009;113(25):6304-14.
2009: David M Asmuth; Ted Wun; Nicole Mullen; Eric Garcia; Erica Chedin; Erica Whitney; Michael Gillis; Kent Anderson; Alice Tarantal; Nicholas J Kenyon; Fitz-Roy E Curry; Lars Berglund
UC Davis CTSA: coming of age: integrated programs help put the spotlight on clinical and translational science.
Clinical and translational science 2009;2(2):98-101.
2009: Wolfgang Hübner; Gregory P McNerney; Ping Chen; Benjamin M Dale; Ronald E Gordon; Frank Y S Chuang; Xiao-Dong Li; David M Asmuth; Thomas Huser; Benjamin K Chen
Quantitative 3D video microscopy of HIV transfer across T cell virological synapses.
Science (New York, N.Y.) 2009;323(5922):1743-7.
2009: Gail Skowron; John G Spritzler; Jodi Weidler; Gregory Robbins; Victoria A Johnson; Ellen S Chan; David M Asmuth; Rajesh T Gandhi; Yolanda Lie; Michael Bates; Richard B Pollard
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):250-8.
2009: Gregory Robbins; John G Spritzler; Ellen S Chan; David M Asmuth; Rajesh T Gandhi; Benigno Rodriguez; Gail Skowron; Paul R Skolnik; Robert W Shafer; Richard B Pollard
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):350-61.
2008: C Seshadri; L O Uiso; Jan Ostermann; H Diefenthal; H J Shao; H Y Chu; David M Asmuth; N M Thielman; J A Bartlett; J A Crump
Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients.
East African medical journal 2008;85(9):442-9.
2008: Bridget E McLaughlin; Nicole Baumgarth; Martin Bigos; Mario Roederer; Stephen C De Rosa; John D Altman; Douglas F Nixon; Janet Ottinger; Carol Oxford; Thomas G Evans; David M Asmuth
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(5):400-10.
2008: Bridget E McLaughlin; Nicole Baumgarth; Martin Bigos; Mario Roederer; Stephen C De Rosa; John D Altman; Douglas F Nixon; Janet Ottinger; Judy Li; Laurel Beckett; Barbara L Shacklett; Thomas G Evans; David M Asmuth
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(5):411-20.
2008: David M Asmuth; Kristina Abel; Michael D George; Satya Dandekar; Richard B Pollard; Christopher J Miller
Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques.
Journal of medical primatology 2008;37(1):26-30.
2007: Stephen J Libertini; Clifford G Tepper; Veronica Rodriguez; David M Asmuth; Hsing-Jien Kung; maria mudryj
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
Cancer research 2007;67(19):9001-5.
2007: L Zhou; Douglas W Kitch; Scott R Evans; Peter Hauer; S Raman; Gigi Ebenezer; M Gerschenson; Christina M Marra; Victor Valcour; Ramon Diaz-Arrastia; K Goodkin; LL Millar; Sharon L Shriver; David M Asmuth; David B Clifford; David M Simpson; justin charles mcarthur
Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.
Neurology 2007;68(24):2113-9.
2007: J William Critchfield; Donna Lemongello; Digna H Walker; Juan C Garcia; David M Asmuth; Richard B Pollard; Barbara L Shacklett
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
Journal of virology 2007;81(11):5460-71.
2006: Rajesh T Gandhi; John Spritzler; Ellen Chan; David M Asmuth; Benigno Rodriguez; Thomas C Merigan; Martin S Hirsch; Robert W Shafer; Gregory Robbins; Richard B Pollard
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):426-34.
2006: David M Simpson; Douglas W Kitch; Scott R Evans; justin charles mcarthur; David M Asmuth; B Cohen; K Goodkin; M Gerschenson; Y So; Christina M Marra; Ramon Diaz-Arrastia; Sharon L Shriver; LL Millar; David B Clifford
HIV neuropathy natural history cohort study: assessment measures and risk factors.
Neurology 2006;66(11):1679-87.
2006: Stephen J Libertini; Clifford G Tepper; MORAIMA GUADALUPE; Ying Lu; David M Asmuth; maria mudryj
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis.
The Prostate 2006;66(1):70-81.
2005: David M Asmuth; Nan Wang; Ying Lu; Xiao-Dong Li; Lisa M Reece; Nicholas H A Terry; Richard B Pollard; Mostafa Nokta; James Leary; R Allen White
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):41-51.
2005: R Allen White; David M Asmuth; Ying Lu; Nan Wang; Xiao-Dong Li; Lisa M Reece; Richard B Pollard; Mostafa Nokta; James Leary; Nicholas H A Terry
Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):32-40.
2005: Franco Lori; Richard B Pollard; Lucia Whitman; Nyasha Bakare; G Blick; P Shalit; Andrea Foli; D Peterson; A Tennenberg; S Schrader; B Rashbaum; C Farthing; D Herman; D Norris; P Greiger; I Frank; Antonella Groff; Luca Lova; David M Asmuth; Julianna Lisziewicz
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
AIDS research and human retroviruses 2005;21(4):263-72.
2004: Michael J Borucki; John Spritzler; David M Asmuth; John W Gnann; Martin S Hirsch; Mostafa Nokta; Francesca T Aweeka; Paul I Nadler; Fred R Sattler; Beverly Alston; Thomas T Nevin; Susan Owens; Karen Waterman; Larry Hubbard; Angela Caliendo; Richard B Pollard
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Antiviral research 2004;64(2):103-11.
2004: David M Asmuth; Hien H Nguyen; Gregory P Melcher; Stuart H Cohen; Richard B Pollard
Treatments for hepatitis B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(9):1353-62.
2004: David M Asmuth; Michael P Busch; Megan E Laycock; Beth A Mohr; Leslie A Kalish; Charles van der Horst
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Antiviral research 2004;63(2):123-31.
2003: R Rossero; David M Asmuth; James J Grady; David McKinsey; S Green; L Andron; Richard B Pollard
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
International journal of STD & AIDS 2003;14(5):350-5.
2003: David M Asmuth; Leslie A Kalish; Megan E Laycock; Edward L Murphy; Beth A Mohr; Tzong-Hae Lee; James Gallarda; Cristina Giachetti; Sheila C Dollard; Charles van der Horst; Robert M Grant; Michael P Busch
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.
Transfusion 2003;43(4):451-8.
2002: Mostafa Nokta; Xiao-Dong Li; Lena Al-Harthi; Joan Nichols; Anna M Pou; David M Asmuth; Alan Landay; Richard B Pollard
Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
AIDS (London, England) 2002;16(16):2119-27.
2002: W Lawrence Drew; Sunwen Chou; Richard C Miner; Beth A Mohr; Michael P Busch; Charles van der Horst; David M Asmuth; Leslie A Kalish
Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.
The Journal of infectious diseases 2002;186(1):114-7.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; Anna M Pou; David M Asmuth; Richard B Pollard
Homeostasis of naive and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of human immunodeficiency virus infection.
The Journal of infectious diseases 2001;183(9):1336-42.
2001: Ann C Collier; Leslie A Kalish; Michael P Busch; Terry Gernsheimer; Susan F Assmann; Thomas A Lane; David M Asmuth; Michael M Lederman; Edward L Murphy; P Kumar; M Kelley; T P Flanigan; D K McMahon; Henry S Sacks; M S Kennedy; P V Holland
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(12):1592-601.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; M Mallen; Anna M Pou; David M Asmuth; Richard B Pollard
Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
AIDS (London, England) 2001;15(2):161-9.
2000: Michael M Lederman; L A Kalish; David M Asmuth; E Fiebig; M Mileno; Michael P Busch
'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
AIDS (London, England) 2000;14(8):951-8.
1996: R Lyon; A K Haque; David M Asmuth; Gail L Woods
Changing patterns of infections in patients with AIDS: a study of 279 autopsies of prison inmates and nonincarcerated patients at a university hospital in eastern Texas, 1984-1993.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(2):241-7.
1995: David M Asmuth; R D Olson; S P Hackett; A E Bryant; R K Tweten; J Y Tso; T Zollman; D L Stevens
Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters.
The Journal of infectious diseases 1995;172(5):1317-23.
1995: Paola C DeGirolami; C R Ezratty; G Desai; A McCullough; David M Asmuth; Christine Wanke; M Federman
Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains.
Journal of clinical microbiology 1995;33(4):805-10.
1994: David M Asmuth; Paola C DeGirolami; M Federman; C R Ezratty; D K Pleskow; G Desai; Christine Wanke
Clinical features of microsporidiosis in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(5):819-25.
1994: David M Asmuth; Scott M Hammer; Christine Wanke
Physiological effects of HIV infection on human intestinal epithelial cells: an in vitro model for HIV enteropathy.
AIDS (London, England) 1994;8(2):205-11.